603207.SHG XIAO FANG ORD A (SHH) EQSW Exp:

Healthcare Drug Manufacturers - Specialty & Generic Shanghai Stock Exchange
22.95 CNY
Close of Nov 5, 2026
20.61 31.39
Market cap
CNY 3.71B
P/E
19.3x
P/B
3.21x
ROE
18.3%
Dividend yield
9.51%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 603207.SHG undervalued?

Graham number
Price22.95
Graham value13.84
Premium65.8%

603207.SHG trades 65.8% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

XIAO FANG ORD A (SHH) EQSW Exp: fundamental analysis

No fundamental analysis for XIAO FANG ORD A (SHH) EQSW Exp: yet.

XIAO FANG ORD A (SHH) EQSW Exp: stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About XIAO FANG ORD A (SHH) EQSW Exp:

Shanghai Xiao Fang Pharmaceutical Co.,Ltd. produces and sells medicines in China and internationally. It offers medicines in the areas of gastroenterology, dermatology, orthopedics, ENT, and disinfection. It also engages in the family health management business. The company was founded in 1993 and is based in Shanghai, China.

Full company profile